Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.755 USD | +0.82% | -10.36% | +0.75% |
May. 13 | Deutsche Bank Adjusts GoodRx Price Target to $8 From $9, Maintains Hold Rating | MT |
May. 09 | Transcript : GoodRx Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 805M | Sales 2025 * | 863M | Capitalization | 2.51B |
---|---|---|---|---|---|
Net income 2024 * | 43M | Net income 2025 * | 84M | EV / Sales 2024 * | 3.05 x |
Net cash position 2024 * | 55.46M | Net cash position 2025 * | 368M | EV / Sales 2025 * | 2.49 x |
P/E ratio 2024 * |
61.8
x | P/E ratio 2025 * |
34.2
x | Employees | 694 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 21.12% |
Latest transcript on GoodRx Holdings, Inc.
1 day | +1.52% | ||
1 week | -10.31% | ||
Current month | -5.63% | ||
1 month | -1.90% | ||
3 months | +4.85% | ||
6 months | +42.25% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Wagner
CEO | Chief Executive Officer | 53 | 23-04-24 |
Trevor Bezdek
FOU | Founder | 46 | 11-08-31 |
Douglas Hirsch
FOU | Founder | 53 | 11-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Agnes Rey-Giraud
BRD | Director/Board Member | 59 | 16-05-31 |
Dipanjan Deb
BRD | Director/Board Member | 54 | 15-09-30 |
Greg Mondre
BRD | Director/Board Member | 49 | 18-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.23% | 9 M€ | +22.75% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 6.755 | +0.82% | 346 247 |
24-05-13 | 6.7 | +1.52% | 1,114,709 |
24-05-10 | 6.6 | -4.76% | 2,014,281 |
24-05-09 | 6.93 | -8.94% | 4,191,342 |
24-05-08 | 7.61 | +1.06% | 3,477,219 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.51B | |
+30.04% | 449B | |
+26.64% | 266B | |
+7.23% | 138B | |
+9.54% | 94.67B | |
+31.46% | 92.57B | |
+54.17% | 57.67B | |
+17.82% | 47.64B | |
+1.36% | 36.17B | |
+23.11% | 37.06B |
- Stock Market
- Equities
- GDRX Stock